Term Gallery logo

Significats de esophageal adenocarcinoma en anglès

Esophageal carcinoma that derives from epithelial cells of glandular origin.

Ús de esophageal adenocarcinoma en anglès
1
Barrett's esophagus is an important step in the pathway to esophageal adenocarcinoma.
Pubmed
2
Context: The incidence of esophageal adenocarcinoma is rising and has surpassed squamous cell carcinoma.
Pubmed
3
Future studies of trastuzumab in esophageal adenocarcinoma are indicated.
Pubmed
4
Barrett's esophagus (BE) is the principal risk factor for esophageal adenocarcinoma.
Pubmed
5
Barrett's esophagus is the precursor lesion for esophageal adenocarcinoma.
Pubmed
6
For esophageal adenocarcinoma, work is needed to develop efficient and effective techniques in mass screening programs.
Pubmed
7
Objectives: Alcohol increases esophageal squamous carcinoma risk but has been less consistently associated with esophageal adenocarcinoma.
Pubmed
8
Barrett's esophagus (BE) is the strongest risk factor for the development of esophageal adenocarcinoma.
Pubmed
9
This review outlines the process of pathogenesis of Barrett's metaplasia and its progression to esophageal adenocarcinoma.
Pubmed
10
Background: The National Comprehensive Cancer Network guidelines recommend consideration of surgery for clinical T4a esophageal adenocarcinoma.
Pubmed
11
Objective: The incidence of esophageal adenocarcinoma has risen rapidly in the past two decades, for unknown reasons.
Pubmed
12
Approximately 80% of high-grade dysplasia and esophageal adenocarcinoma cases demonstrated strong to moderate Akt activity.
Pubmed
13
Reflux-induced injury promotes esophageal adenocarcinoma, one of the most rapidly increasing, highly lethal cancers in Western countries.
Pubmed
14
Surgery should be considered for medically fit patients with cT4aN0-3M0 esophageal adenocarcinoma.
Pubmed
15
Our clinical study indicates esophageal adenocarcinoma patients on metformin had a better treatment response than those without metformin.
Pubmed
16
Background: Barrett's esophagus (BE) is known to progress to esophageal adenocarcinoma in a setting of chronic inflammation.
Pubmed
Aquesta col·locació està formada per:
Esophageal adenocarcinoma per variant geogràfica
Estats Units d'Amèrica
Comú